Author
Listed:
- Avraham Yaron
(The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School)
- Ada Hatzubai
(The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School)
- Matti Davis
(The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School)
- Iris Lavon
(The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School)
- Sharon Amit
(The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School)
- Anthony M. Manning
(Signal Pharmaceuticals Inc.)
- Jens S. Andersen
(Protana A/S)
- Matthias Mann
(Protana A/S)
- Frank Mercurio
(Signal Pharmaceuticals Inc.)
- Yinon Ben-Neriah
(The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School)
Abstract
NF-κB, a ubiquitous, inducible transcription factor involved in immune, inflammatory, stress and developmental processes, is retained in a latent form in the cytoplasm of non-stimulated cells by inhibitory molecules, IκBs1,2,3. Its activation is a paradigm for a signal-transduction cascade that integrates an inducible kinase and the ubiquitin–proteasome system to eliminate inhibitory regulators. Here we isolate the pIκBα–ubiquitin ligase (pIκBα-E3) that attaches ubiquitin, a small protein which marks other proteins for degradation by the proteasome system, to the phosphorylated NF-κB inhibitor pIκBα. Taking advantage of its high affinity to pIκBα, we isolate this ligase from HeLa cells by single-step immunoaffinity purification. Using nanoelectrospray mass spectrometry, we identify the specific component of the ligase that recognizes the pIκBα degradation motif as an F-box/WD-domainprotein belonging to a recently distinguished family of β-TrCP/Slimb proteins. This component, which we denote E3RSIκB (pIκBα-E3 receptor subunit), binds specifically to pIκBα and promotes its in vitro ubiquitination in the presence of two other ubiquitin-system enzymes, E1 and UBC5C, one of many known E2 enzymes. An F-box-deletion mutant of E3RSIκB, which tightly binds pIκBα but does not support its ubiquitination, acts in vivo as a dominant-negative molecule, inhibiting the degradation of pIκBα and consequently NF-κB activation. E3RSIκB represents a family of receptor proteins that are core components of a class of ubiquitin ligases. When these receptor components recognize their specific ligand, which is a conserved, phosphorylation-based sequence motif, they target regulatory proteins containing this motif for proteasomal degradation.
Suggested Citation
Avraham Yaron & Ada Hatzubai & Matti Davis & Iris Lavon & Sharon Amit & Anthony M. Manning & Jens S. Andersen & Matthias Mann & Frank Mercurio & Yinon Ben-Neriah, 1998.
"Identification of the receptor component of the IκBα–ubiquitin ligase,"
Nature, Nature, vol. 396(6711), pages 590-594, December.
Handle:
RePEc:nat:nature:v:396:y:1998:i:6711:d:10.1038_25159
DOI: 10.1038/25159
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:396:y:1998:i:6711:d:10.1038_25159. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.